Assistant Professor, Medicine, University of Colorado School of Medicine
Endocrinology
Dr. Joshua P. Klopper, MD
|
|
Give Review
Joshua P. Klopper, MD practices Endocrinology. He studied medicine at Emory University School of Medicine. Emory University School of Medicine is ranked 23/42 in Research/PrimaryCare. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Dr. Joshua P. Klopper is a published doctor. He has 22 papers published. The most current publication "A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer." Joshua Klopper is registered with Medicare and accepts Medicare payments.
Publications
- A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer.
- Database and registry research in Thyroid cancer: Striving for a new and improved national Thyroid cancer database.
- What is the "Gold Standard" for comprehensive inter-institutional communication of perioperative information for Thyroid cancer patients? A comparison of existing elec...
- Improving the Quality of Thyroid Cancer Care: How Does the Thyroid Cancer Care Collaborative Cross the Institute of Medicine's Quality Chasm?
- A review of the management of recurrent and persistent metastatic lymph nodes in well differentiated Thyroid cancer: A multifactorial decision making guide created for...
- Multicenter Clinical Experience With the Afirma Gene Expression Classifier.
- Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic Thyroid cancer: results of a multicenter phase 1 trial.
- Programmed Death-1+ T Cells and Regulatory T Cells Are Enriched in Tumor-Involved Lymph Nodes and Associated with Aggressive Features in Papillary Thyroid Cancer.
- Consumptive HypoThyroidism Resulting from Hepatic Vascular Tumors in an Athyreotic Adult.
- Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism.
- Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary Thyroid cancer.
- Combination PPARgamma and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2.
- Molecular testing for mutations in improving the fine-needle aspiration diagnosis of Thyroid nodules.
- Deoxyribonucleic acid profiling analysis of 40 human Thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.
- In vivo and microarray analysis of rexinoid-responsive anaplastic Thyroid carcinoma.
- Retinoid X receptor-gamma and peroxisome proliferator-activated receptor-gamma expression predicts Thyroid carcinoma cell response to retinoid and thiazolidinedione tr...
- Retinoic acid and retinoid X receptors are differentially expressed in Thyroid cancer and Thyroid carcinoma cell lines and predict response to treatment with retinoids.
- Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression.
- Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic Thyroid carcinoma tumor growth via p21WAF1/CIP1.
- Palpable pediatric thyroid Abnormalities - diagnostic pitfalls necessitate a high index of clinical suspicion: a case report.
- Can calcitonin and carcinoembryonic antigen doubling times predict progression of Thyroid carcinoma?
Schools
Emory University School Of Medicine
University Of Colorado
Conditions Treated
- Abnormal Thyroid
- Acromegaly and Gigantism
- Adrenal Insufficiency
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Colorado -
Emory University School of Medicine
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1952322141 | |
| NPPES Provider LastName | KLOPPER | |
| NPPES Provider FirstName | JOSHUA | |
| NPPES Provider ZIPCode | 802620001 | |
| NPPES Provider State | CO | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 104.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952322141 |
| Last Name Of The Provider | KLOPPER |
| First Name Of The Provider | JOSHUA |
| View All |
Similar Doctors
|
Dr. Janice M. Kerr, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eli C. Ridgway III, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark P. Bridenstine, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bryan R. Haugen, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Victoria A. Catenacci, MD
This Doctor is OpenDoctor Recommended.
|